Trial intelligence / Profile preview

Comparative efficacy of tacrolimus 0.1% vs fluocinolone ointment in cutaneous lichen planus

IRCT201407263566N4Phase 4Completed

Sponsor
Tabriz University of Medical Sciences
Start
May 2014
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tacrolimus in Cutaneous Lichen Planus (CLP) (2 arms), sponsored by Tabriz University of Medical Sciences. Started May 2014; status: completed.

02

Drugs

tacrolimus
03

Conditions

Cutaneous Lichen Planus (CLP)

Beyond the preview

Go deeper on IRCT201407263566N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201407263566N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call